182 related articles for article (PubMed ID: 30348039)
1. A Regional Analysis of Hepatitis C Virus Collaborative Care With Pharmacists in Indian Health Service Facilities.
Geiger R; Steinert J; McElwee G; Carver J; Montanez R; Niewoehner J; Clark C; Reilley B
J Prim Care Community Health; 2018; 9():2150132718807520. PubMed ID: 30348039
[TBL] [Abstract][Full Text] [Related]
2. An Evaluation of Hepatitis C Virus Telehealth Services Serving Tribal Communities: Patterns of Usage, Evolving Needs, and Barriers.
Stephens D; Leston J; Terrault NA; Gailloux K; Mera J; Essex W; Reilley B
J Public Health Manag Pract; 2019; 25 Suppl 5, Tribal Epidemiology Centers: Advancing Public Health in Indian Country for Over 20 Years():S97-S100. PubMed ID: 31348196
[TBL] [Abstract][Full Text] [Related]
3. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Treatment Cascade in a Federally Qualified Health Center.
Hachey DM; Holmes JT; Aubuchon-Endsley NL
J Community Health; 2020 Apr; 45(2):264-268. PubMed ID: 31512110
[TBL] [Abstract][Full Text] [Related]
5. Assessing Disparities in the Rates of HCV Diagnoses Within American Indian or Alaska Native Populations Served by the U.S. Indian Health Service, 2005-2015.
Reilley B; Leston J; Doshani M; Haberling DL; Person M; Weiser T; Collier M; Iralu J; Mera J; Haverkate R
J Community Health; 2018 Dec; 43(6):1115-1118. PubMed ID: 29808445
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program - Cherokee Nation, Oklahoma, 2015-2020.
Essex W; Feder M; Mera J
MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(22):597-600. PubMed ID: 37262000
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.
Gauthier TP; Moreira E; Chan C; Cabrera A; Toro M; Carrasquillo MZ; Corentin M; Sherman EM
J Am Pharm Assoc (2003); 2016; 56(6):670-676. PubMed ID: 27667501
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of treatment access and scope of a multistate hepatitis C virus Extension for Community Healthcare Outcomes telehealth service in the US Indian Health System, 2017-2021.
Wirth AN; Cushman NA; Reilley BA; Leston JD; Mera JR; Levander XA; Stephens DJ
J Rural Health; 2023 Mar; 39(2):358-366. PubMed ID: 36526593
[TBL] [Abstract][Full Text] [Related]
9. Increasing access for veterans with hepatitis C by enhancing use of clinical pharmacy specialists.
Ourth HL; Groppi JA; Morreale AP; Jorgenson T; Himsel AS; Jacob DA
J Am Pharm Assoc (2003); 2019; 59(3):398-402. PubMed ID: 30853345
[TBL] [Abstract][Full Text] [Related]
10. Pharmacist-led drug therapy management for hepatitis C at a federally qualified health care center.
Downes JM; Donovan A; McAdam-Marx C
J Am Pharm Assoc (2003); 2022; 62(5):1596-1605. PubMed ID: 35595639
[TBL] [Abstract][Full Text] [Related]
11. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.
Duvivier H; Gustafson S; Greutman M; Jangchup T; Harden AK; Reinhard A; Warshany K
J Am Pharm Assoc (2003); 2017; 57(2S):S135-S140. PubMed ID: 28292501
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacy programmatic perspectives on use of direct-acting antivirals for acquired hepatitis C infection in solid organ transplant recipients.
Crona L; Berry H; Byrns J; Campbell U
Am J Health Syst Pharm; 2020 Jul; 77(14):1149-1152. PubMed ID: 32537658
[TBL] [Abstract][Full Text] [Related]
13. Pharmacist-driven multidisciplinary pretreatment workup process for hepatitis C care: A novel model for same-day pretreatment workup.
Houck KK; Ifeachor AP; Fleming BS; Andres AM; O'Donovan KN; Johnson AJ; Liangpunsakul S
J Am Pharm Assoc (2003); 2019; 59(5):710-716. PubMed ID: 31227418
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of a Pharmacist-Led Hepatitis C Virus Treatment Program in an Urban Safety-Net Health System, Chicago, 2017-2019.
Hunt BR; Cetrone H; Sam S; Glick NR
Public Health Rep; 2022; 137(4):702-710. PubMed ID: 34043923
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of pharmacist care delivery models for hepatitis C clinics.
Naidjate SS; Zullo AR; Dapaah-Afriyie R; Hersey ML; Marshall BDL; Winkler RM; Berard-Collins C
Am J Health Syst Pharm; 2019 May; 76(10):646-653. PubMed ID: 30873537
[TBL] [Abstract][Full Text] [Related]
16. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
17. Birth Cohort Testing for Hepatitis C Virus - Indian Health Service 2012-2015.
Reilley B; Leston J; Hariri S; Neel L; Rudd M; Galope M; Ward J; Vellozzi C
MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):467-9. PubMed ID: 27171026
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Treatment: Clinical Issues for Psychiatrists in the Post-Interferon Era.
Chasser Y; Kim AY; Freudenreich O
Psychosomatics; 2017; 58(1):1-10. PubMed ID: 27871760
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C in pregnant American Indian and Alaska native women; 2003-2015.
Nolen LD; O'Malley JC; Seeman SS; Bruden DJT; Apostolou A; McMahon BJ; Bruce MG
Int J Circumpolar Health; 2019 Dec; 78(1):1608139. PubMed ID: 31025610
[TBL] [Abstract][Full Text] [Related]
20. Indian health service innovations have helped reduce health disparities affecting american Indian and alaska native people.
Sequist TD; Cullen T; Acton KJ
Health Aff (Millwood); 2011 Oct; 30(10):1965-73. PubMed ID: 21976341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
